» Articles » PMID: 38510198

LGBTQ+ Cardiovascular Health Equity: A brief review

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States. Data shows that social drivers of health (SDOH), including economic stability, racial/cultural identity, and community, have a significant impact on cardiovascular morbidity and mortality. LGBTQ+ (lesbian, gay, bisexual, transgender, queer, and other gender and sexual minority) patients face a variety of unique health risk factors and bear a disproportionate burden of CVD compared to cis-gender, heterosexual peers. There is a paucity of research assessing the etiologies of CVD health disparities within the LGBTQ+ community. Herein, we seek to explore existing literature on LGBTQ+ health disparities with a focus on cardiovascular disease, examine trends impacting LGBTQ+ health equity, and identify strategies and interventions that aim to promote LGBTQ+ cardiovascular health equity on a regional and national level.

Citing Articles

Intersectionality and Social Drivers of Health in Cardiovascular Care.

Hurwitz M, Bonomo J, Spitz J, Sharma G Methodist Debakey Cardiovasc J. 2024; 20(5):98-110.

PMID: 39525384 PMC: 11546069. DOI: 10.14797/mdcvj.1436.


Omics Science and Social Aspects in Detecting Biomarkers for Diagnosis, Risk Prediction, and Outcomes of Carotid Stenosis.

Costa D, Scalise E, Ielapi N, Bracale U, Faga T, Michael A Biomolecules. 2024; 14(8).

PMID: 39199360 PMC: 11353051. DOI: 10.3390/biom14080972.

References
1.
Meyer I . Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: conceptual issues and research evidence. Psychol Bull. 2003; 129(5):674-697. PMC: 2072932. DOI: 10.1037/0033-2909.129.5.674. View

2.
Frank D, Johnson A, Hausmann L, Gellad W, Roberts E, Vajravelu R . Disparities in Guideline-Recommended Statin Use for Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and Gender : A Nationally Representative Cross-Sectional Analysis of Adults in the United States. Ann Intern Med. 2023; 176(8):1057-1066. PMC: 10804313. DOI: 10.7326/M23-0720. View

3.
Caceres B, Sharma Y, Doan D . Hypertension risk in sexual and gender minority individuals. Expert Rev Cardiovasc Ther. 2022; 20(5):339-341. PMC: 9233064. DOI: 10.1080/14779072.2022.2075345. View

4.
Aranda G, Halperin I, Gomez-Gil E, Hanzu F, Segui N, Guillamon A . Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population. Front Endocrinol (Lausanne). 2021; 12:718200. PMC: 8515285. DOI: 10.3389/fendo.2021.718200. View

5.
Alzahrani T, Nguyen T, Ryan A, Dwairy A, McCaffrey J, Yunus R . Cardiovascular Disease Risk Factors and Myocardial Infarction in the Transgender Population. Circ Cardiovasc Qual Outcomes. 2019; 12(4):e005597. DOI: 10.1161/CIRCOUTCOMES.119.005597. View